MOST CITED SCHOLAR PUBLICATIONS
- Guillain-Barr syndrome related to SARS-CoV-2 infectionK Bigaut, M Mallaret, S Baloglu, B Nemoz, P Morand, F Baicry, A Godon, ...Neurology: Neuroimmunology & Neuroinflammation 7 (5), e785 2020Citations: 126
- Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I/501Y. V1 (B. 1.1. 7, variant of concern 202012/01) in France, January to March 2021A Gaymard, P Bosetti, A Feri, G Destras, V Enouf, A Andronico, S Burrel, ...Eurosurveillance 26 (9), 2100133 2021Citations: 82
- Mapping of potent and specific binding motifs, GLOGEN and GVOGEA, for integrin α1β1 using collagen toolkits II and IIISW Hamaia, N Pugh, N Raynal, B Nmoz, R Stone, D Gullberg, D Bihan, ...Journal of Biological Chemistry 287 (31), 26019-26028 2012Citations: 73
- Teaching NeuroImages: SARS-CoV-2–related encephalitis: MRI pattern of olfactory tract involvementO Casez, G Willaume, S Grand, B Nemoz, J Lupo, P Kahane, JP BrionNeurology 96 (4), e645-e646 2021Citations: 29
- Simultaneous quantification of adalimumab and infliximab in human plasma by liquid chromatography–tandem mass spectrometryJF Jourdil, B Nmoz, E Gautier-Veyret, C Romero, F Stanke-LabesqueTherapeutic Drug Monitoring 40 (4), 417-424 2018Citations: 19
- SARS-CoV-2 nosocomial infection acquired in a French university hospital during the 1st wave of the Covid-19 pandemic, a prospective studyA Landoas, F Cazzorla, M Gallouche, S Larrat, B Nemoz, C Giner, ...Antimicrobial Resistance & Infection Control 10, 1-8 2021Citations: 16
- Norcarfentanil: carfentanil misuse or remifentanil treatment?N Allibe, N Fouilhe Sam-Lai, T Willeman, JF Jourdil, M Bartoli, M Mallaret, ...Forensic Toxicology 37, 488-495 2019Citations: 14
- Evaluation of six commercial SARS-CoV-2 rapid antigen tests in nasopharyngeal swabs: Better knowledge for better patient management?J Andreani, J Lupo, R Germi, C Laugier, M Roccon, S Larrat, P Morand, ...Journal of Clinical Virology 143, 104947 2021Citations: 13
- Guillain-Barr syndrome related to SARS-CoV-2 infection. Neurol Neuroimmunol Neuroinflamm. 2020; 7 (5): e785K Bigaut, M Mallaret, S Baloglu, B Nemoz, P Morand, F Baicry 2020Citations: 13
- Evaluation of the cobas GT hepatitis C virus genotyping assay in G1-6 viruses including low viral loads and LiPA failuresB Nmoz, L Roger, V Leroy, JD Poveda, P Morand, S LarratPlos one 13 (3), e0194396 2018Citations: 13
- Persistence at one year of neutralizing antibodies after SARS-CoV-2 infection: Influence of initial severity and steroid useO Epaulard, M Buisson, B Nemoz, M Le Marchal, N Terzi, JF Payen, ...The Journal of Infection 84 (3), 418 2022Citations: 10
- Hepatitis C subtype distribution in chronically infected patients with mild liver fibrosis in France: the GEMHEP studyT Semenova, B Nemoz, V Thibault, G Lagathu, G Duverlie, E Brochot, ...Epidemiology & Infection 147, e234 2019Citations: 7
- New steps in infliximab therapeutic drug monitoring in patients with inflammatory bowel diseasesB Nemoz, D Ternant, S Bailly, E Gautier‐Veyret, JF Jourdil, B Bonaz, ...British Journal of Clinical Pharmacology 85 (4), 722-728 2019Citations: 6
- COVID-19 in clinical practice: A narrative synthesisM Le Marechal, P Morand, O Epaulard, B NemozMedecine et Maladies Infectieuses 50 (8), 639-647 2020Citations: 4
- Guillain-Barr syndrome related to SARS-CoV-2 infection. Neurol Neuroimmunol Neuroinflamm 7 (5): e785K Bigaut, M Mallaret, S Baloglu, B Nemoz, P Morand, F Baicry, A Godon, ... 2020Citations: 4
- Norcarfentanil, un mtabolite d’intrt dans le diagnostic toxicologique: propos de 3 hospitalisationsH Eysseric, N Allibe, NF Sam-La, M Bartoli, R Bruyre, D Protar, ...Toxicologie Analytique et Clinique 30 (2), S48-S49 2018Citations: 2
- Risk factors for nosocomial COVID-19 in a French university hospitalC Dinh, M Gallouche, H Terrisse, K Gam, C Giner, B Nemoz, S Larrat, ...Infectious Diseases Now 53 (5), 104695 2023Citations: 1
- Use of RT-PCR thermocycling program for the quantification of DNA viruses in a single run with RNA viruses: example of Altona RealStar HSV or VZV PCR kitsJ Andreani, J Lupo, B Nemoz, A Truffot, S Larrat, P Morand, R GermiInfectious Diseases Now 2022Citations: 1
- Risk factors of nosocomial Covid-19 in a French university hospital: a case-control studyC Dinh, M Gallouche, H Terrisse, K Gam, C Giner, B Nemoz, S Larrat, ... 2022Citations: 1
- COVID-19 geographical maps and clinical data warehouse PREDIMEDS Artemova, A Caporossi, C Canc, PE Madiot, B Nemoz, S Larrat, ...MEDINFO 2021: One World, One Health–Global Partnership for Digital 2022Citations: 1